Learn More
Ciprofloxacin Hydrochloride, MP Biomedicals™
Very effective against a broad spectrum of bacteria and mycoplasma. Ciprofloxacin Hydrochloride, MP Biomedicals is a fluorinated quinolone antibacterial agent. Typically used for 12–20 days in cell culture media, with the media being changed every 3
$100.49 - $639.22
Chemical Identifiers
CAS | 86393-32-0 |
---|---|
Molecular Formula | C17H21ClFN3O4 |
Molecular Weight (g/mol) | 385.82 |
MDL Number | MFCD00242856 |
InChI Key | ARPUHYJMCVWYCZ-UHFFFAOYSA-N |
Synonym | Cipro, Ciproxan, 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O |
PubChem CID | 62998 |
ChEBI | CHEBI:59936 |
IUPAC Name | hydrogen 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrate chloride |
SMILES | [H+].O.[Cl-].OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O |
Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
MP219902005
|
MP Biomedicals Inc
0219902005 |
5 g |
Each for $100.49
|
|
|||||
MP219902025
|
MP Biomedicals Inc
0219902025 |
25 g |
Each for $399.49
|
|
|||||
MP219902050
|
MP Biomedicals Inc
0219902050 |
50 g |
Each for $639.22
|
|
|||||
Description
During the proliferation phase of a bacterium, a segmental twisting and untwisting of the chromosomes takes place. An enzyme called DNA gyrase plays a decisive part in this process. Ciprofloxacin inhibits this DNA gyrase in a way that arrests the bacterial metabolism, since vital information can no longer be read from the bacterial chromosome. Ultimately, it affects DNA replication and cell division.
Ciprofloxacin is most commonly used to treat infections of the skin, bone, sinus, lung, abdomen, and bladder. It can also be used to treat some sexually transmitted infections. Additionally, ciprofloxacin can be used after exposure to inhalation of anthrax to reduce the chance of developing an infection.
Chemical Identifiers
86393-32-0 | |
385.82 | |
ARPUHYJMCVWYCZ-UHFFFAOYSA-N | |
62998 | |
hydrogen 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrate chloride |
C17H21ClFN3O4 | |
MFCD00242856 | |
Cipro, Ciproxan, 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O | |
CHEBI:59936 | |
[H+].O.[Cl-].OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O |
Specifications
Powder | |
3.7 (2% aq. soln.) (literature) | |
5 g | |
MFCD00242856 | |
Stock solutions can be prepared in water or 0.1M NaOH (1-10mg/mL). | |
[H+].O.[Cl-].OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O | |
385.82 | |
CHEBI:59936 |
86393-32-0 | |
313°C to 322°C | |
C17H21ClFN3O4 | |
Cipro, Ciproxan, 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O | |
ARPUHYJMCVWYCZ-UHFFFAOYSA-N | |
hydrogen 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrate chloride | |
62998 | |
367.8g/mol (anhyd.) |
Safety and Handling
Recommended Storage : Store at 4°C.